Joint Supplements: An Osteopath’s Honest Guide

The most common question I hear after a first visit is: “Dottore, should I take a supplement for my joints?” Here is the honest answer: one category has reasonable evidence (collagen peptides paired with vitamin C, protein, creatine, vitamin D, magnesium); one is worth considering in specific situations (curcumin, boswellia, omega-3); and one is a clear waste of money for most people (glucosamine and chondroitin, MSM). The 2019 American College of Rheumatology guideline — the largest and most recent specialist consensus — conditionally recommends against glucosamine and chondroitin for knee and hip osteoarthritis ¹. A 2023 meta-analysis of 4 randomised controlled trials covering 507 patients found collagen peptides reduced knee pain scores significantly, though evidence quality was rated ‘very low’ ³. What follows is my evidence-based traffic-light rating for each ingredient, with citations so you can read the source yourself.

How do I read the evidence?

Three things matter most: (1) whether there are randomised controlled trials (RCTs) or meta-analyses, not just animal studies or industry-sponsored pilot data; (2) what the big specialist guidelines conclude — because they synthesise all the evidence, not just the flattering trials; and (3) whether the effect size is clinically meaningful, not just statistically significant. A supplement that reduces a pain score by 0.3 points on a 10-point scale may be ‘statistically significant’ with enough participants — it may not be worth €30 a month.

Which supplements have the best evidence for joints? (Traffic-light table)

	Ingredient	Evidence base	Verdict
🟢	Collagen peptides + vitamin C	2023 meta-analysis, 4 RCTs, 507 pts ³; EU-authorised claim: vitamin C → normal collagen formation for cartilage ¹⁵	Worth trying — 10 g/day, minimum 3 months, pair with vitamin C
🟢	Protein (adequate daily intake)	Robust evidence for muscle-mass preservation in over-50s; 1.2–1.6 g/kg/day recommended ⁷	Most people under-eat protein — fix diet first, supplement if needed
🟢	Creatine monohydrate	Meta-analyses support increased lean mass and strength in older adults doing resistance training ⁷	Best combined with resistance exercise; 3–5 g/day
🟢	Vitamin D	EU-authorised claim for normal muscle function ¹⁵; supplementation reduces musculoskeletal pain in deficient patients ⁹	Get blood levels checked first — supplement only if deficient
🟢	Magnesium	EU-authorised claims: muscle function, tiredness reduction, electrolyte balance ¹⁵; systematic review shows role in sarcopenia prevention ⁸	Broad benefit, low risk — especially useful if diet is poor
🟡	Curcumin (turmeric extract)	2024 Bayesian NMA: better than placebo for knee OA pain ⁵; lower GI risk than NSAIDs; poor bioavailability an issue	Situational — enhanced-bioavailability formulations only; not a substitute for diagnosis
🟡	Boswellia serrata	2024 systematic review and meta-analysis shows significant pain reduction vs placebo ⁶; study quality low-to-moderate	Situational — meaningful benefit for some; limited long-term safety data
🟡	Omega-3 (EPA/DHA)	Modest anti-inflammatory effect in inflammatory arthritis; weaker evidence for OA specifically; cardiovascular benefit well-established	Worthwhile for overall health; joint benefit is modest and secondary
🔴	Glucosamine + chondroitin	ACR 2019: conditionally recommends against ¹; OARSI 2019: recommends against ²; no EU-authorised joint claim ¹⁴	Save your money — evidence does not justify routine use
🔴	MSM (methylsulfonylmethane)	2008 systematic review: limited, low-quality evidence only ¹⁰; no subsequent high-quality meta-analysis; no EU-authorised claim	Save your money — insufficient evidence

Green: the supplements worth considering

Collagen peptides are the most relevant green-tier supplement specifically for joint tissue. A 2023 meta-analysis in the Journal of Orthopaedic Surgery and Research — the paper I cite most often to patients — pooled 4 randomised trials with 507 knee-osteoarthritis patients and found a statistically significant reduction in pain ³. The honest caveats: evidence quality was rated ‘very low’ by the GRADE system, most trials were short (under 6 months), and effect sizes were modest. The pairing with vitamin C is the single most evidence-backed connection in this area: EU Regulation 432/2012 authorises the claim that vitamin C contributes to normal collagen formation for the normal function of cartilage ¹⁵. A 2023 review in the Journal of the International Society of Sports Nutrition also found collagen peptide supplementation improved function and reduced pain across active adults ⁴.

Protein, creatine, vitamin D, and magnesium belong to the green tier for a different reason: they support the muscle and metabolic foundations that joints depend on. Most people over 50 eat significantly less protein than the 1.2–1.6 g per kilogram of body weight per day recommended for muscle-mass preservation — no supplement fixes what inadequate diet causes ⁷. Creatine monohydrate has a solid meta-analytic evidence base for increasing lean mass and lower-limb strength in older adults who combine it with resistance training ⁷. Vitamin D has an EU-authorised claim for normal muscle function ¹⁵ and a 2017 systematic review in Clinical Rheumatology found that supplementation significantly reduced chronic non-specific musculoskeletal pain in patients who were deficient ⁹. Magnesium carries EU-authorised claims for muscle function, reduction of tiredness, and electrolyte balance; a systematic review linking mineral status to sarcopenia prevention in older adults found magnesium one of the most consistent associations ⁸.

Yellow: situational — better than nothing, but read the small print

Curcumin (the active compound in turmeric) has attracted genuine research attention. A 2024 Bayesian network meta-analysis in the Journal of Ethnopharmacology found curcumin superior to placebo for both pain and function in knee osteoarthritis, and noted its lower gastrointestinal risk compared with non-steroidal anti-inflammatory drugs ⁵. However, plain curcumin from food or standard supplements is poorly absorbed — most positive trials used phospholipid-complexed, nanoparticle, or piperine-enhanced formulations. A 2022 systematic review found similar benefits but flagged low-to-moderate study quality across the literature. I place curcumin in yellow rather than green because the delivery-form dependency makes real-world results less predictable, and no major guideline has moved it to a positive recommendation for joint disease.

Boswellia serrata (Indian frankincense) shows similar promise at the individual-study level. A 2024 systematic review and meta-analysis in Phytotherapy Research found significant reductions in pain and improvements in function compared with placebo for knee osteoarthritis, though it noted that study quality was generally low to moderate and long-term safety data remain limited ⁶. Omega-3 fatty acids (EPA and DHA) have a well-established cardiovascular evidence base and a plausible anti-inflammatory mechanism; the evidence for joint-specific benefit in osteoarthritis is more modest than for inflammatory arthritis (rheumatoid arthritis), where guidelines are more supportive.

We conditionally recommend against the use of glucosamine for patients with knee, hip, and/or hand osteoarthritis, and conditionally recommend against the use of chondroitin sulfate for patients with knee and/or hip osteoarthritis.

Red: save your money

Glucosamine and chondroitin are the most widely sold joint supplements in Italy and among the most recommended by pharmacists. The evidence, however, does not support them. The 2019 ACR guideline conditionally recommends against both for knee, hip and hand osteoarthritis ¹. The 2019 OARSI guideline (the international osteoarthritis research body) likewise recommends against them for knee and hip OA ². The MOVES trial — one of the largest RCTs, comparing the combination against celecoxib in painful knee OA — found the combination non-inferior to celecoxib in a subgroup of patients with moderate-to-severe pain, but the study design has been criticised and the result has not shifted the major guidelines ¹³. An important honest footnote: the ESCEO (European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis) working group maintains a minority position that prescription-grade crystalline glucosamine sulphate — a specific pharmaceutical form not equivalent to most pharmacy supplements — may have modest structure-modifying effects ¹¹¹². This view is not the consensus, but it is held by serious researchers and is worth noting. The practical implication for most patients: the glucosamine on a pharmacy shelf is not the same compound studied in ESCEO-cited trials.

MSM (methylsulfonylmethane) has even thinner evidence. A systematic review in Osteoarthritis and Cartilage — the field’s leading journal — found only limited, low-quality evidence that it outperforms placebo for pain relief ¹⁰. No high-quality meta-analysis has changed that picture. I have no hesitation saying: spend that money elsewhere.

What does the label actually say? EU health claims and why this matters

In the European Union, food supplement labels are tightly regulated. Under Regulation (EC) No 1924/2006 on nutrition and health claims ¹⁴, a company may only print a health claim if it has been approved by the European Food Safety Authority (EFSA) and is listed in Regulation (EU) 432/2012 ¹⁵. The practical implications are striking. Vitamin C, vitamin D, magnesium, and creatine all have authorised claims linked to muscle or connective-tissue function. Glucosamine has no authorised EU health claim for joints or cartilage — none — because EFSA reviewed the evidence and found it insufficient to establish a cause-and-effect relationship. The same is true for chondroitin, MSM, and most boswellia and curcumin products (which may only make generic botanical claims under different rules).

This matters because supplement packaging in Italy frequently carries phrases like “supporta la cartilagine” or “per la salute delle articolazioni”. These claims are permitted as general function claims or under botanical regulations with a lower evidential threshold than EFSA’s rigorous standard. The fine for making an unauthorised nutrition or health claim in Italy ranges from €6,000 to €24,000 under Legislative Decree 27/2017 implementing Regulation 1924/2006 — but the marketing threshold for prosecution is high enough that borderline phrasing is common. When a label says something is “good for joints” in italic text, it is not necessarily backed by the same evidence standard as an authorised EFSA claim. Ask: is there an authorised EU claim? If not, the label is marketing, not medicine.

My honest bottom line

I am not against supplements. I am against paying for supplements that the evidence does not support when the money could go towards physiotherapy, resistance training, or a better diet — all of which have stronger effects on joint health than any pill. If you are deficient in vitamin D, supplement it. If you are over 50 and under-eating protein, fix that first and consider creatine if you are doing resistance training. If you want to try collagen peptides with vitamin C for 3 months, the evidence is modest but not unreasonable and the risk is very low. And if you are currently spending money on glucosamine, chondroitin, or MSM: the evidence does not support them, the EU regulator agrees, and you have my honest permission to stop.

Already taking supplements for pain or joints? Bring the bottles to your first visit — we’ll review them together, no extra cost and nothing to sell you. → Book / WhatsApp

FAQ

Do glucosamine and chondroitin work for joint pain?

The current evidence does not support routine use. Both the 2019 American College of Rheumatology guideline and the 2019 OARSI guideline conditionally recommend against glucosamine and chondroitin for knee and hip osteoarthritis. Neither compound holds an EU-authorised health claim for joints under Regulation 1924/2006. An honest minority view exists: the ESCEO working group argues that prescription-grade crystalline glucosamine sulphate may have modest benefits, but this is not the mainstream guideline position. If you are already taking it and feel it helps, discuss stopping or continuing with your doctor — do not stop abruptly without advice.

Is collagen worth taking for joint pain?

Collagen peptides show more promise than glucosamine, but the effect is modest. A 2023 meta-analysis in the Journal of Orthopaedic Surgery and Research pooled 4 RCTs with 507 knee-osteoarthritis patients and found a statistically significant reduction in pain scores, though the quality of evidence was rated very low. The most biologically plausible mechanism involves pairing collagen with vitamin C: EU Regulation 432/2012 authorises the claim that vitamin C contributes to normal collagen formation for the normal function of cartilage. Expect at least 3 months at 10 g/day before judging the effect.

Can curcumin (turmeric) help with arthritis pain?

Possibly, for some people. A 2024 Bayesian network meta-analysis found curcumin superior to placebo for knee osteoarthritis pain and function, and a useful feature is its lower gastrointestinal risk compared with NSAIDs. However, bioavailability is a real issue — plain curcumin is poorly absorbed, and most positive trials use enhanced formulations. Study quality across the literature is generally low to moderate. I would not call it a reliable treatment, but it is unlikely to cause harm at typical doses and may reduce reliance on anti-inflammatory drugs for some patients.

Should I take vitamin D for joint or back pain?

If you are deficient — which is common in Italy, especially in winter, or if you spend little time outdoors — correcting that deficiency may reduce musculoskeletal pain. A 2017 systematic review in Clinical Rheumatology found that vitamin D supplementation significantly reduced chronic non-specific musculoskeletal pain scores in deficient patients. Vitamin D also has an EU-authorised claim for normal muscle function. A blood test from your GP will tell you whether you are actually deficient before you spend money on a supplement that may not be needed.

Is magnesium useful for muscles and joints?

Magnesium has solid EU-authorised claims for normal muscle function, reduction of tiredness, and electrolyte balance (Regulation 432/2012). It is one of the more broadly useful supplements on this list, particularly for people whose diet is low in nuts, seeds, legumes, and green leafy vegetables — the best dietary sources. Evidence for magnesium specifically reducing joint pain is thinner, but supporting overall muscle function is clearly relevant to musculoskeletal health. Deficiency is common and supplementation is low-risk at standard doses.

What about MSM for joints?

The evidence for methylsulfonylmethane (MSM) is thin. A 2008 systematic review in Osteoarthritis and Cartilage found only limited, low-quality evidence that MSM reduces pain compared with placebo. No high-quality meta-analysis has changed that picture significantly since. MSM holds no EU-authorised health claim for joints. It is unlikely to be harmful, but ‘unlikely to be harmful’ is not the same as ‘worth the money’. I would put that budget towards protein, vitamin D or magnesium, all of which have stronger evidence for musculoskeletal health.

Get the printable sheet (free)

Supplements for joints and back pain: an osteopath’s honest guide